Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas

Despite the widespread clinical use of dynamic susceptibility contrast (DSC) MRI, DSC-MRI methodology has not been standardized, hindering its utilization for response assessment in multicenter trials. Recently, the DSC-MRI Standardization Subcommittee of the Jumpstarting Brain Tumor Drug Developmen...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Neuro Oncol
Päätekijät: Boxerman, Jerrold L, Quarles, Chad C, Hu, Leland S, Erickson, Bradley J, Gerstner, Elizabeth R, Smits, Marion, Kaufmann, Timothy J, Barboriak, Daniel P, Huang, Raymond H, Wick, Wolfgang, Weller, Michael, Galanis, Evanthia, Kalpathy-Cramer, Jayashree, Shankar, Lalitha, Jacobs, Paula, Chung, Caroline, van den Bent, Martin J, Chang, Susan, Al Yung, W K, Cloughesy, Timothy F, Wen, Patrick Y, Gilbert, Mark R, Rosen, Bruce R, Ellingson, Benjamin M, Schmainda, Kathleen M
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2020
Aiheet:
Reviews
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7523451/
https://ncbi.nlm.nih.gov/pubmed/32516388
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa141
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia